Tuesday, 30 November 2021

An F.D.A. panel endorses Merck’s Covid pill for high-risk adults.


By BY REBECCA ROBBINS AND CARL ZIMMER from NYT Health https://ift.tt/3E5iiI1

South African Company Nears License to Sell J. & J. Covid Shot Across Africa


By BY STEPHANIE NOLEN from NYT Health https://ift.tt/3FYzOOL

South African Company Nears License to Sell J. & J. Covid Shot Across Africa


By BY STEPHANIE NOLEN from NYT Health https://ift.tt/3D8Czev

Omicron: What Is Known — and Still Unknown


By BY ANDREW JACOBS from NYT Health https://ift.tt/3llGSNv

Regeneron says its antibody treatment may not be as effective against Omicron, but testing is underway.


By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3EaJuoT

A panel of F.D.A. advisers is set to discuss Merck’s Covid pill.


By BY REBECCA ROBBINS AND CARL ZIMMER from NYT Health https://ift.tt/3lnhk2t

Counterfeit Covid Masks Are Still Sold Everywhere, Despite Misleading Claims


By BY ANDREW JACOBS from NYT Health https://ift.tt/3o6e1i4

Thursday, 25 November 2021

Saturday, 20 November 2021

Thursday, 18 November 2021

The first known Covid case was a vendor at a Wuhan market, a scientist claims.


By BY CARL ZIMMER, BENJAMIN MUELLER AND CHRIS BUCKLEY from NYT Health https://ift.tt/3nsyz3J

First Known Covid Case Was Vendor at Wuhan Market, Scientist Claims


By BY CARL ZIMMER, BENJAMIN MUELLER AND CHRIS BUCKLEY from NYT Health https://ift.tt/3x3SiKy